FTC Accuses Hims & Hers of Data Misuse and Deceptive Billing

Telehealth giant Hims & Hers is currently facing legal action from the Federal Trade Commission (FTC), in collaboration with the states of Utah and California. This lawsuit stems from a prolonged investigation into the company's handling of sensitive customer health information. The core allegations revolve around the company's purported sharing of patient data with advertisers and major technology firms such as Meta and Snap, despite explicit assurances of data protection. Additionally, the legal complaint asserts that Hims & Hers engages in misleading billing and cancellation tactics, including making it difficult for users to terminate subscriptions and misrepresenting the process for charging new patients for prescriptions before medical consultation. Hims & Hers has refuted these accusations, contending that the FTC's actions are not rooted in consumer protection but rather an attempt to generate negative publicity at their expense.
FTC Alleges Hims & Hers Shared Private Customer Data and Used Deceptive Billing
In a significant legal development on July 29, the Federal Trade Commission (FTC), supported by the state attorneys general of Utah and California, officially accused the prominent telehealth company, Hims & Hers, of compromising consumer data privacy. This legal challenge emerges from a multi-year inquiry into the firm's practices concerning sensitive health information. The central claim made by the FTC is that Hims & Hers provided lists of customer names and detailed site behavior data to advertising entities and technology giants, including Meta and Snap. This alleged data sharing occurred despite the company's explicit commitments to safeguard customer data. The FTC argues that these actions violate the FTC Act and the Restore Online Shoppers’ Confidence Act.
Beyond data privacy concerns, the lawsuit also highlights alleged deceptive billing and subscription cancellation policies. Specifically, the FTC contends that Hims & Hers misleads customers into believing that they will not be charged for prescriptions until after a medical consultation. However, the legal filing suggests that many customers are prompted to provide billing details and subsequently charged for prescription plans shortly after completing initial intake forms, often before receiving a physician's review of their medications. Furthermore, the FTC alleges that the company has implemented cumbersome cancellation procedures, making it challenging for users to terminate their subscriptions, thereby violating consumer protection principles.
Hims & Hers, in a public statement, has vehemently denied the accusations. The company asserts that the FTC has disregarded pertinent evidence uncovered during its investigation and has overlooked existing state laws and industry standards. They characterize the lawsuit as an unfair targeting, suggesting it is motivated by a desire for headlines rather than genuine consumer protection. This legal battle underscores the ongoing challenges and scrutiny faced by telehealth platforms in balancing rapid growth with stringent privacy regulations and ethical business practices.
This case serves as a crucial reminder of the growing scrutiny placed on companies, especially those in the telehealth sector, regarding data privacy and transparent business practices. In an era where personal health information is increasingly digitized, the responsibility to protect this data is paramount. Companies must not only adhere to legal requirements but also prioritize building and maintaining consumer trust through clear, ethical, and secure data handling policies. Moreover, the ease of cancelling subscriptions and transparent billing should be standard, ensuring consumers are not trapped in services they no longer desire. This lawsuit could set an important precedent for how telehealth providers manage data and interact with their customers in the future.